Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.

Abstract

Obesity is an established risk factor for postmenopausal breast cancer (BCa), insulin resistance, and vitamin D deficiency, and all contribute to increased synthesis of mammary estrogens, the drivers of estrogen receptor-positive (ER+) BCa growth. As both dietary vitamin D and calcitriol treatments inhibit breast estrogen synthesis and signaling, we hypothesized that vitamin D would be especially beneficial in mitigating the adverse effects of obesity on ER+BCa. To assess whether obesity exerted adverse effects on BCa growth and whether vitamin D compounds could reduce these unfavorable effects, we employed a diet-induced obesity (DIO) model in ovariectomized C57BL/6 mice. Breast tumor cells originally from syngeneic Mmtv-Wnt1 transgenic mice were then implanted into the mammary fat pads of lean and obese mice. DIO accelerated the initiation and progression of the mammary tumors. Treatments with either calcitriol or dietary vitamin D reduced the adverse effects of obesity causing a delay in tumor appearance and inhibiting continued tumor growth. Beneficial actions of treatments with vitamin D or calcitriol on BCa and surrounding adipose tissue included repressed Esr1, aromatase, and Cox2 expression; decreased tumor-derived estrogen and PGE2; reduced expression of leptin receptors; and increased adiponectin receptors. We demonstrate that vitamin D treatments decreased insulin resistance, reduced leptin, and increased adiponectin signaling and also regulated the LKB1/AMPK pathway contributing to an overall decrease in local estrogen synthesis in the obese mice. We conclude that calcitriol and dietary vitamin D, acting by multiple interrelated pathways, mitigate obesity-enhanced BCa growth in a postmenopausal setting.

• Authors: Srilatha Swami, Aruna V Krishnan, Jasmaine Williams, Abhishek Aggarwal, Megan A Albertelli, Ronald L Horst, Brian J Feldman, David Feldman
• Journal: Endocrine-related cancer (Endocr Relat Cancer) Vol. 23 Issue 4 Pg. 251-64 (Apr 2016) ISSN: 1479-6821 [Electronic] England
• PMID: 26817629 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: © 2016 Society for Endocrinology.

Chemical References

• Adiponectin
• Adipoq protein, mouse
• Estrogens
• Leptin
• RNA, Messenger
• Vitamin D
• Estrone
• Estradiol
• Aromatase
• Ptgs2 protein, mouse
• Cyclooxygenase 2
• AMP-Activated Protein Kinases
• Dinoprostone
• Calcium

Topics

• AMP-Activated Protein Kinases (metabolism)
• Adiponectin (blood)
• Adipose Tissue (drug effects, metabolism)
• Animals
• Aromatase (genetics)
• Calcium (blood)
• Cyclooxygenase 2 (genetics)
• Diet, High-Fat
• Dietary Supplements
• Dinoprostone (metabolism)
• Estradiol (metabolism)
• Estrogens (metabolism)
• Estrone (metabolism)
• Female
• Humans
• Leptin (blood)
• MCF-7 Cells
• Mammary Glands, Animal (metabolism, pathology)
• Mammary Neoplasms, Experimental (blood, metabolism, pathology)
• Mice
• Mice, Inbred C57BL
• Obesity (blood, complications, metabolism, pathology)
• Ovariectomy
• RNA, Messenger (metabolism)
• Tumor Burden
• Vitamin D (blood, pharmacology)